Vaccine provides protection against five diseases

Infanrix-IPV+Hib is a multi-component vaccine that provides protection against diphtheria, tetanus, pertussis, polio and invasive diseases caused by Haemophilus influenzae type b.

Infanrix-IPV+Hib is appropriate for the active immunisation of children from age two months.

Primary immunisation is a course of two or three doses, separated by a minimum of four weeks between each dose. A booster dose should be given at least six months after the last priming dose, preferably between 11 and 13 months of age. The vaccine is not suitable for children over 36 months of age.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB1 1BT. Tel: (0800) 221441.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

A woman wearing a white vest as a blue-gloved hand of a healthcare professional are seen injecting a vaccine.

'Nocebo' effect may cause two-thirds of COVID-19 vaccine reactions, study suggests

Two-thirds of adverse reactions reported with the COVID-19...

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...